Panacea Biotec announces new chief financial officer, company secretary

Panacea Biotec Limited announced significant changes to its Key Managerial Personnel (KMP) and Senior Management Personnel (SMP), effective December 16, 2025. This follows the resignation of Devender Gupta as chief financial officer, effective December 15, 2025.

Vinod Goel, currently group CFO, head legal and company secretary, and compliance officer, will assume the role of chief financial officer, designated as group chief financial officer and head legal and corporate governance. Consequently, Goel will cease to be the company secretary and compliance officer as of December 15, 2025.

In a related appointment, Ankit Jain, assistant general manager - legal of Panacea Biotec Pharma Ltd., a wholly-owned subsidiary, has been promoted to company secretary and compliance officer, designated as general manager - legal and company secretary, also effective December 16, 2025. These appointments were approved by the board of directors.

Furthermore, Panacea Biotec revised its policy for determining the materiality of events and authorized key managerial personnel to make disclosures to the stock exchange(s) under SEBI LODR Regulation, effective December 16, 225. The authorized personnel include Dr. Rajesh Jain, Sandeep Jain, Ankesh Jain, Harshet Jain, Dr. Sanjay Trehan, Vinod Goel, and Ankit Jain.